1. PeekRMJr, BlaserMJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer2002;2:28. CrossRef

2. PeekRMJr, FiskeC, WilsonKT. Role of innate immunity in Helicobacter pylori‐induced gastric malignancy. Physiol Rev2010;90:831. CrossRef

3. PolkDB, PeekRMJr. Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer2010;10:403. CrossRef

4. MarshallBJ, ArmstrongJA, McGechieDB, et al.Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med J Aust1985;142:436.

5. MarshallBJ, WarrenJR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet1984;1(8390):1311. CrossRef

6. CorreaP. Helicobacter pylori and gastric cancer: state of the art. Cancer Epidemiol Biomarkers Prev1996;5:477.

7. DixonMF, GentaRM, YardleyJH, et al.Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol1996;20:1161. CrossRef

8. RuggeM, PennelliG, PilozziE, et al.Gastritis: the histology report. Dig Liver Dis2011;43(Suppl 4):S373. CrossRef

9. ErikssonNK, FarkkilaMA, VoutilainenME, et al.The clinical value of taking routine biopsies from the incisura angularis during gastroscopy. Endoscopy2005;37:532. CrossRef

10. CarrNJ, LeadbetterH, MarriottA. Correlation between the endoscopic and histologic diagnosis of gastritis. Ann Diagn Pathol2012;16:13. CrossRef

11. El‐ZimaityHMT, OtaH, GrahamDY, et al.Patterns of gastric atrophy in intestinal type gastric carcinoma. Cancer2002;94:1428. CrossRef

12. WeisVG, GoldenringJR. Current understanding of SPEM and its standing in the preneoplastic process. Gastric Cancer2009;12:189. CrossRef

13. ErnstPB, PeuraDA, CroweSE. The translation of Helicobacter pylori basic research to patient care. Gastroenterology2006;130:188. CrossRef

14. EverhartJE. Recent developments in the epidemiology of Helicobacter pylori. Gastroenterol Clin North Am2000;29:559. CrossRef

15. ErnstPB, GoldBD. The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu Rev Microbiol2000;54:615. CrossRef

16. TindbergY, BengtssonC, GranathF, et al.Helicobacter pylori infection in Swedish school children: lack of evidence of child‐to‐child transmission outside the family. Gastroenterology2001;121:310. CrossRef

17. ParsonnetJ, ShmuelyH, HaggertyT. Fecal and oral shedding of Helicobacter pylori from healthy infected adults. JAMA1999;282:2240. CrossRef

18. Meyer‐RosbergK, ScottDR, RexD, et al.The effect of environmental pH on the proton motive force of Helicobacter pylori. Gastroenterology1996;111:886. CrossRef

19. EatonKA, KrakowkaS. Effect of gastric pH on urease‐dependent colonization of gnotobiotic piglets by Helicobacter pylori. Infect Immun1994;62:3604.

20. SkouloubrisS, ThibergeJM, LabigneA, et al.The Helicobacter pylori UreI protein is not involved in urease activity but is essential for bacterial survival in vivo. Infect Immun1998;66:4517.

21. EatonKA, SuerbaumS, JosenhansC, et al.Colonization of gnotobiotic piglets by Helicobacter pylori deficient in two flagellin genes. Infect Immun1996;64:2445.

22. TanS, NotoJM, Romero‐GalloJ, et al.Helicobacter pylori perturbs iron trafficking in the epithelium to grow on the cell surface. PLoS Pathog2011;7:e1002050. CrossRef

23. CookeCL, HuffJL, SolnickJV. The role of genome diversity and immune evasion in persistent infection with Helicobacter pylori. FEMS Immunol Med Microbiol2005;45:11. CrossRef

24. GerhardM, LehnN, NeumayerN, et al.Clinical relevance of the Helicobacter pylori gene for blood‐group antigen‐binding adhesin. Proc Natl Acad Sci U S A1999;96:12778. CrossRef

25. IlverD, ArnqvistA, OgrenJ, et al.Helicobacter pylori adhesin binding fucosylated histo‐blood group antigens revealed by retagging. Science1998;279:373. CrossRef

26. MahdaviJ, SondenB, HurtigM, et al.Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science2002;297:573. CrossRef

27. SolnickJV, HansenLM, SalamaNR, et al.Modification of Helicobacter pylori outer membrane protein expression during experimental infection of rhesus macaques. Proc Natl Acad Sci U S A2004;101:2106. CrossRef

28. KawakuboM, ItoY, OkimuraY, et al.Natural antibiotic function of a human gastric mucin against Helicobacter pylori infection. Science2004;305:1003. CrossRef

29. GobertAP, McGeeDJ, AkhtarM, et al.Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Proc Natl Acad Sci U S A2001;98:13844. CrossRef

30. DonnellyMA, SteinerTS. Two nonadjacent regions in enteroaggregative Escherichia coli flagellin are required for activation of toll‐like receptor 5. J Biol Chem2002;277:40456. CrossRef

31. GewirtzAT, NavasTA, LyonsS, et al.Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol2001;167:1882. CrossRef

32. TakedaK, KaishoT, AkiraS. Toll‐like receptors. Annu Rev Immunol2003;21:335. CrossRef

33. Andersen‐NissenE, SmithKD, StrobeKL, et al.Evasion of Toll‐like receptor 5 by flagellated bacteria. Proc Natl Acad Sci U S A2005;102:9247. CrossRef

34. BlaserMJ, AthertonJC. Helicobacter pylori persistence: biology and disease. J Clin Invest2004;113:321. CrossRef

35. GewirtzAT, YuY, KrishnaUS, et al.Helicobacter pylori flagellin evades toll‐like receptor 5‐mediated innate immunity. J Infect Dis2004;189:1914. CrossRef

36. LeeSK, StackA, KatzowitschE, et al.Helicobacter pylori flagellins have very low intrinsic activity to stimulate human gastric epithelial cells via TLR5. Microbes Infect2003;5:1345. CrossRef

37. BoncristianoM, PaccaniSR, BaroneS, et al.The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms. J Exp Med2003;198:1887. CrossRef

38. GebertB, FischerW, WeissE, et al.Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science2003;301:1099. CrossRef

39. SundrudMS, TorresVJ, UnutmazD, et al.Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL‐2 secretion. Proc Natl Acad Sci U S A2004;101:7727. CrossRef

40. AmievaMR, SalamaNR, TompkinsLS, et al.Helicobacter pylori enter and survive within multivesicular vacuoles of epithelial cells. Cell Microbiol2002;4:677. CrossRef

41. NecchiV, CandussoME, TavaF, et al.Intracellular, intercellular, and stromal invasion of gastric mucosa, preneoplastic lesions, and cancer by Helicobacter pylori. Gastroenterology2007;132:1009. CrossRef

42. OhJD, KaramSM, GordonJI. Intracellular Helicobacter pylori in gastric epithelial progenitors. Proc Natl Acad Sci U S A2005;102:5186. CrossRef

43. ZhengPY, JonesNL. Helicobacter pylori strains expressing the vacuolating cytotoxin interrupt phagosome maturation in macrophages by recruiting and retaining TACO (coronin 1) protein. Cell Microbiol2003;5:25. CrossRef

44. KaoJY, ZhangM, MillerMJ, et al.Helicobacter pylori immune escape is mediated by dendritic cell‐induced Treg skewing and Th17 suppression in mice. Gastroenterology2010;138:1046. CrossRef

45. NagaiS, MimuroH, YamadaT, et al.Role of Peyer's patches in the induction of Helicobacter pylori‐induced gastritis. Proc Natl Acad Sci U S A2007;104:8971. CrossRef

46. BimczokD, ClementsRH, WaitesKB, et al.Human primary gastric dendritic cells induce a Th1 response to H. pylori. Mucosal Immunol2010;3:260. CrossRef

47. WilsonKT, CrabtreeJE. Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies. Gastroenterology2007;133:288. CrossRef

48. WroblewskiLE, PeekRMJr, WilsonKT. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev2010;23:713. CrossRef

49. RobinsonK, KenefeckR, PidgeonEL, et al.Helicobacter pylori‐induced peptic ulcer disease is associated with inadequate regulatory T cell responses. Gut2008;57:1375. CrossRef

50. SipponenP, MarshallBJ. Gastritis and gastric cancer. Western countries. Gastroenterol Clin North Am2000;29:579. CrossRef

51. YouWC, ZhangL, GailMH, et al.Precancerous lesions in two counties of China with contrasting gastric cancer risk. Int J Epidemiol1998;27:945. CrossRef

52. AlmRA, LingLS, MoirDT, et al.Genomic‐sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature1999;397:176. Erratum in: Nature 1999;397:719. CrossRef

53. GoMF, KapurV, GrahamDY, et al.Population genetic analysis of Helicobacter pylori by multilocus enzyme electrophoresis: extensive allelic diversity and recombinational population structure. J Bacteriol1996;178:3934.

54. SalamaN, GuilleminK, McDanielTK, et al.A whole‐genome microarray reveals genetic diversity among helicobacter pylori strains. Proc Natl Acad Sci U S A2000;97:14668. CrossRef

55. TombJF, WhiteO, KerlavageAR, et al.The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature1997;388:539. Erratum in: Nature 1997;389:412. CrossRef

56. IsraelDA, SalamaN, KrishnaU, et al.Helicobacter pylori genetic diversity within the gastric niche of a single human host. Proc Natl Acad Sci U S A2001;98:14625. CrossRef

57. AkopyantsNS, CliftonSW, KersulyteD, et al.Analyses of the cag pathogenicity island of Helicobacter pylori. Mol Microbiol1998;28:37. CrossRef

58. CensiniS, LangeC, XiangZ, et al.cag, a pathogenicity island of Helicobacter pylori, encodes type I‐ specific and disease‐associated virulence factors. Proc Natl Acad Sci U S A1996;93:14648. CrossRef

59. CovacciA, RappuoliR. Tyrosine‐phosphorylated bacterial proteins: trojan horses for the host cell. J Exp Med2000;191:587. CrossRef

60. OdenbreitS, PulsJ, SedlmaierB, et al.Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science2000;287:1497. CrossRef

61. HayashiT, SendaM, MorohashiH, et al.Tertiary structure‐function analysis reveals the pathogenic signaling potentiation mechanism of Helicobacter pylori oncogenic effector CagA. Cell Host Microbe2012;12:20. CrossRef

62. Murata‐KamiyaN, KikuchiK, HayashiT, et al.Helicobacter pylori exploits host membrane phosphatidylserine for delivery, localization, and pathophysiological action of the CagA oncoprotein. Cell Host Microbe2010;7:399. CrossRef

63. HigashiH, TsutsumiR, FujitaA, et al.Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci U S A2002;99:14428. CrossRef

64. ChurinY, Al‐GhoulL, KeppO, et al.Helicobacter pylori CagA protein targets the c‐Met receptor and enhances the motogenic response. J Cell Biol2003;161:249. CrossRef

65. FrancoAT, IsraelDA, WashingtonMK, et al.Activation of β‐catenin by carcinogenic Helicobacter pylori. Proc Natl Acad Sci U S A2005;102:10646. CrossRef

66. Murata‐KamiyaN, KurashimaY, TeishikataY, et al.Helicobacter pylori CagA interacts with E‐cadherin and deregulates the beta‐catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene2007;26:4617. CrossRef

67. SaadatI, HigashiH, ObuseC, et al.Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature2007;447:330. CrossRef

68. ChaturvediR, AsimM, Romero‐GalloJ, et al.Spermine oxidase mediates the gastric cancer risk associated with Helicobacter pylori CagA. Gastroenterology2011;141:1696. CrossRef

69. ButiL, SpoonerE, Van der VeenAG, et al.Helicobacter pylori cytotoxin‐associated gene A (CagA) subverts the apoptosis‐stimulating protein of p53 (ASPP2) tumor suppressor pathway of the host. Proc Natl Acad Sci U S A2011;108:9238. CrossRef

70. WeiJ, NotoJ, ZaikaE, et al.Pathogenic bacterium Helicobacter pylori alters the expression profile of p53 protein isoforms and p53 response to cellular stresses. Proc Natl Acad Sci U S A2012;109:E2543. CrossRef

71. VialaJ, ChaputC, BonecaIG, et al.Nod1 responds to peptidoglycan delivered by the Helicobacter pyloricag pathogenicity island. Nat Immunol2004;5:1166. CrossRef

72. BoughanPK, ArgentRH, Body‐MalapelM, et al.Nucleotide‐binding oligomerization domain‐1 and epidermal growth factor receptor: critical regulators of beta‐defensins during Helicobacter pylori infection. J Biol Chem2006;281:11637. CrossRef

73. WatanabeT, AsanoN, Fichtner‐FeiglS, et al.NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway. J Clin Invest2010;120:1645. CrossRef

74. NagyTA, FreyMR, YanF, et al.Helicobacter pylori regulates cellular migration and apoptosis by activation of phosphatidylinositol 3‐kinase signaling. J Infect Dis2009;199:641. CrossRef

75. NagyTA, WroblewskiLE, WangD, et al.beta‐Catenin and p120 mediate PPARdelta‐dependent proliferation induced by Helicobacter pylori in human and rodent epithelia. Gastroenterology2011;141:553. CrossRef

76. CoverTL, BlankeSR. Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat Rev Microbiol2005;3:320. CrossRef

77. RheadJL, LetleyDP, MohammadiM, et al.A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology2007;133:926. CrossRef

78. AthertonJC, CaoP, PeekRMJr, et al.Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem1995;270:17771. CrossRef

79. CoverTL, BlaserMJ. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem1992;267:10570.

80. Van DoornLJ, FigueiredoC, MegraudF, et al.Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology1999;116:823. CrossRef

81. ChungC, OlivaresA, TorresE, et al.Diversity of VacA intermediate region among Helicobacter pylori strains from several regions of the world. J Clin Microbiol2010;48:690. CrossRef

82. DossumbekovaA, PrinzC, MagesJ, et al.Helicobacter pylori HopH (OipA) and bacterial pathogenicity: genetic and functional genomic analysis of hopH gene polymorphisms. J Infect Dis2006;194:1346. CrossRef

83. BorenT, FalkP, RothKA, et al.Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science1993;262:1892. CrossRef

84. GurugeJL, FalkPG, LorenzRG, et al.Epithelial attachment alters the outcome of Helicobacter pylori infection. Proc Natl Acad Sci U S A1998;95:3925. CrossRef

85. YamaokaY, OjoO, FujimotoS, et al.Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut2006;55:775. CrossRef

86. NoachLA, BosmaNB, JansenJ, et al.Mucosal tumor necrosis factor‐alpha, interleukin‐1 beta, and interleukin‐8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol1994;29:425. CrossRef

87. El‐OmarEM, CarringtonM, ChowWH, et al.Interleukin‐1 polymorphisms associated with increased risk of gastric cancer. Nature2000;404:398. CrossRef

88. FigueiredoC, MachadoJC, PharoahP, et al.Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high‐risk individuals for gastric carcinoma. J Natl Cancer Inst2002;94:1680. CrossRef

89. SantosJC, LadeiraMS, PedrazzoliJJr, et al.Relationship of IL‐1 and TNF‐alpha polymorphisms with Helicobacter pylori in gastric diseases in a Brazilian population. Braz J Med Biol Res2012;45:811. CrossRef

90. El‐OmarEM, RabkinCS, GammonMD, et al.Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology2003;124:1193. CrossRef

91. SakitaniK, HirataY, HayakawaY, et al.Role of interleukin‐32 in Helicobacter pylori‐induced gastric inflammation. Infect Immun2012;80:3795. CrossRef

92. MalfertheinerP, MegraudF, O'MorainCA, et al.Management of Helicobacter pylori infection – the Maastricht IV/ Florence Consensus Report. Gut2012;61:646. CrossRef

93. BassetC, HoltonJ, GattaL, et al.Helicobacter pylori infection: anything new should we know?Aliment Pharmacol Ther2004;20(Suppl 2):31. CrossRef

94. MakristathisA, HirschlAM, LehoursP, et al.Diagnosis of Helicobacter pylori infection. Helicobacter2004;9(Suppl 1):7. CrossRef

95. WangXI, ZhangS, AbreoF, et al.The role of routine immunohistochemistry for Helicobacter pylori in gastric biopsy. Ann Diagn Pathol2010;14:256. CrossRef

96. AbdallaAM, SordilloEM, HanzelyZ, et al.Insensitivity of the CLO test for H. pylori, especially in the elderly. Gastroenterology1998;115:243. CrossRef

97. el‐ZimaityHM, al‐AssiMT, GentaRM, et al.Confirmation of successful therapy of Helicobacter pylori infection: number and site of biopsies or a rapid urease test. Am J Gastroenterol1995;90:1962.

98. El‐ZimaityHM, GrahamDY. Evaluation of gastric mucosal biopsy site and number for identification of Helicobacter pylori or intestinal metaplasia: role of the Sydney System. Hum Pathol1999;30:72. CrossRef

99. Abdel‐WahabM, AttallahAM, ElshalMF, et al.Cellular proliferation and ploidy of the gastric mucosa: the role of Helicobacter pylori. Hepatogastroenterology1997;44:880.

100. XiaHX, KeaneCT, O'MorainCA. Pre‐formed urease activity of Helicobacter pylori as determined by a viable cell count technique – clinical implications. J Med Microbiol1994;40:435. CrossRef

101. Abreu‐MartinMT, VidrichA, LynchDH, et al.Divergent induction of apoptosis and IL‐8 secretion in HT‐29 cells in response to TNF‐alpha and ligation of Fas antigen. J Immunol1995;155:4147.

102. PeekRMJr, MillerGG, ThamKT, et al.Heightened inflammatory response and cytokine expression in vivo to cagA+Helicobacter pylori strains. Lab Invest1995;73:760.

103. BanatvalaN, LopezCR, OwenR, et al.Helicobacter pylori in dental plaque. Lancet1993;341:380. CrossRef

104. BassoD, NavagliaF, CassaroM, et al.Gastric juice polymerase chain reaction: an alternative to histology in the diagnosis of Helicobacter pylori infection. Helicobacter1996;1:159. CrossRef

105. JiangC, LiC, HaT, et al.Identification of H. pylori in saliva by a nested PCR assay derived from a newly cloned DNA probe. Dig Dis Sci1998;43:1211. CrossRef

106. KellySM, PitcherMC, FarmerySM, et al.Isolation of Helicobacter pylori from feces of patients with dyspepsia in the United Kingdom. Gastroenterology1994;107:1671.

107. LiC, HaT, FergusonDA, et al.A newly developed PCR assay of H. pylori in gastric biopsy, saliva, and feces. Evidence of high prevalence of H. pylori in saliva supports oral transmission. Dig Dis Sci1996;41:2142. CrossRef

108. AchtmanM, AzumaT, BergDE, et al.Recombination and clonal groupings within Helicobacter pylori from different geographical regions. Mol Microbiol1999;32:459. CrossRef

109. AibaY, SuzukiN, KabirAM, et al.Lactic acid‐mediated suppression of Helicobacter pylori by the oral administration of Lactobacillussalivarius as a probiotic in a gnotobiotic murine model. Am J Gastroenterol1998;93:2097. CrossRef

110. AiharaM, TsuchimotoD, TakizawaH, et al.Mechanisms involved in Helicobacter pylori‐induced interleukin‐8 production by a gastric cancer cell line, MKN45. Infect Immun1997;65:3218.

111. LeodolterA, VairaD, BazzoliF, et al.European multicentre validation trial of two new non‐invasive tests for the detection of Helicobacter pylori antibodies: urine‐based ELISA and rapid urine test. Aliment Pharmacol Ther2003;18:927. CrossRef

112. OkudaM, NakazawaT, BookaM, et al.Evaluation of a urine antibody test for Helicobacter pylori in Japanese children. J Pediatr2004;144:196. CrossRef

113. ShimizuT, YaritaY, HarunaH, et al.Urine‐based enzyme‐linked immunosorbent assay for the detection of Helicobacter pylori antibodies in children. J Paediatr Child Health2003;39:606. CrossRef

114. CutlerAF, PrasadVM, SantogadeP. Four‐year trends in Helicobacter pylori IgG serology following successful eradication. Am J Med1998;105:18. CrossRef

115. KosunenTU, SeppalaK, SarnaS, et al.Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet1992;339:893. CrossRef

116. AleljungP, NilssonHO, WangX, et al.Gastrointestinal colonisation of BALB/cA mice by Helicobacter pylori monitored by heparin magnetic separation. FEMS Immunol Med Microbiol1996;13:303. CrossRef

117. VairaD, MalfertheinerP, MegraudF, et al.Diagnosis of Helicobacter pylori infection with a new non‐invasive antigen‐based assay. HpSA European study group. Lancet1999;354:30. CrossRef

118. PeekRM. Helicobacter pylori and gastroesophageal reflux disease. Curr Treat Options Gastroenterol2004;7:59. CrossRef

119. MiehlkeS, BayerdorfferE, GrahamDY. Treatment of Helicobacter pylori infection. Semin Gastrointest Dis2001;12:167.

120. UlmerHJ, BeckerlingA, GatzG. Recent use of proton pump inhibitor‐based triple therapies for the eradication of H pylori: a broad data review. Helicobacter2003;8:95. CrossRef

121. VairaD, ZulloA, HassanC, et al.Sequential therapy for Helicobacter pylori eradication: the time is now!Ther Adv Gastroenterol2009;2:317. CrossRef

122. RomanoM, CuomoA, GravinaAG, et al.Empirical levofloxacin‐containing versus clarithromycin‐containing sequential therapy for Helicobacter pylori eradication: a randomised trial. Gut2010;59:1465. CrossRef

123. GreenbergER, AndersonGL, MorganDR, et al.14‐day triple, 5‐day concomitant, and 10‐day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial. Lancet2011;378:507. CrossRef

124. SaadRJ, SchoenfeldP, KimHM, et al.Levofloxacin‐based triple therapy versus bismuth‐based quadruple therapy for persistent Helicobacter pylori infection: a meta‐analysis. Am J Gastroenterol2006;101:488. CrossRef

125. WilliamsC. Occurrence and significance of gastric colonization during acid‐inhibitory therapy. Best Pract Res Clin Gastroenterol2001;15:511. CrossRef

126. PaikDC, LarsonJD, JohnsonSA, et al.Phlegmonous gastritis and group A streptococcal toxic shock syndrome in a patient following functional endoscopic sinus surgery. Surg Infect (Larchmt)2010;11:545. CrossRef

127. KavalarR, SkokP, KrambergerKG. Phlegmonous gastritis in a patient with rheumatoid arthritis. Wien Klin Wochenschr2005;117:364. CrossRef

128. LeeBS, KimSM, SeongJK, et al.Phlegmonous gastritis after endoscopic mucosal resection. Endoscopy2005;37:490. CrossRef

129. LiftonLJ, ShlossbergD. Phlegmonas gastritis after endoscopic polypectomy. Ann Intern Med1982;97:373. CrossRef

130. OcepekA, SkokP, ViragM, et al.Emphysematous gastritis – case report and review of the literature. Z Gastroenterol2004;42:735. CrossRef

131. Lam‐HimlinD, TsiatisAC, MontgomeryE, et al.Sarcina organisms in the gastrointestinal tract: a clinicopathologic and molecular study. Am J Surg Pathol2011;35:1700. CrossRef

132. LauwersGY, FujitaH, NagataK, et al.Pathology of non‐Helicobacter pylori gastritis: extending the histopathologic horizons. J Gastroenterol2010;45:131. CrossRef

133. FerradaPA. Successful surgical treatment of emphysematous gastritis on a patient with poor cardiac function. Am Surg2012;78:66.

134. HuangC‐T, LiaoW‐Y. Emphysematous gastritis: a deadly infectious disease. Scand J Infect Dis2009;41:317. CrossRef

135. DebongnieJC, DonnayM, MairesseJ. Gastrospirillum hominis (“Helicobacter heilmanii”): a cause of gastritis, sometimes transient, better diagnosed by touch cytology?Am J Gastroenterol1995;90:411.

136. MassironiS, CarmagnolaS, PenaginiR, et al.Gastric involvement in a patient with secondary syphilis. Dig Liver Dis2005;37:368. CrossRef

137. GuerreroAF, StraightTM, EastoneJ, et al.Gastric syphilis in an HIV‐infected patient. AIDS Patient Care STDS2005;19:281. CrossRef

138. AmarapurkarDN, PatelND, AmarapurkarAD. Primary gastric tuberculosis – report of 5 cases. BMC Gastroenterol2003;3:6. CrossRef

139. BodmerT, MiltnerE, BermudezLE. Mycobacterium avium resists exposure to the acidic conditions of the stomach. FEMS Microbiol Lett2000;182:45. CrossRef

140. MaioranaA, BaccariniP, ForoniM, et al.Human cytomegalovirus infection of the gastrointestinal tract in apparently immunocompetent patients. Hum Pathol2003;34:1331. CrossRef

141. SarkioS, HalmeL, ArolaJ, et al.Gastroduodenal cytomegalovirus infection is common in kidney transplantation patients. Scand J Gastroenterol2005;40:508. CrossRef

142. ChangHR. Posttransplant cytomegalovirus disease presenting with pyloric obstruction. Transplantation2005;79:1462. CrossRef

143. SferraTJ, PawelBR, QualmanSJ. Menetrier disease of childhood: role of cytomegalovirus and transforming growth factor alpha. J Pediatr1996;128:213. CrossRef

144. HiejimaE, YasumiT, KubotaH, et al.Gastric ulcer and gastroenteritis caused by Epstein‐Barr virus during immunosuppressive therapy for a child with systemic juvenile idiopathic arthritis. Rheumatology2012;51:2107. CrossRef

145. HisamatsuA, NagaiT, OkawaraH, et al.Gastritis associated with Epstein‐Barr virus infection. Intern Med2010;49:2101. CrossRef

146. Zwolinska‐WcisloM, BudakA, BogdalJ, et al.Fungal colonization of gastric mucosa and its clinical relevance. Med Sci Monit2001;7:982.

147. SanguinoJ, RodriguesB, BaptistaA, et al.Focal lesion of African histoplasmosis present as a malignant gastric ulcer. Hepatogastroenterology1996;43:771.

148. WashingtonK, GottfriedMR, WilsonML. Gastrointestinal crytococcosis. Mod Pathol1991;4:707.

149. StammB. Mucormycosis of the stomach in a patient with multiple trauma. Histopathology2005;47:222. CrossRef

150. PampiglioneS, RivasiF, CriscuoloM, et al.Human anisakiasis in Italy: a report of eleven new cases. Pathol Res Pract2002;198:429. CrossRef

151. MoonA, SpivakW, BrandtLJ. Cryptosporidium‐induced gastric obstruction in a child with congenital HIV infection: case report and review of the literature. J Pediatr Gastroenterol Nutr1999;28:108. CrossRef

152. DoglioniC, De BoniM, CieloR, et al.Gastric giardiasis. J Clin Pathol1992;45:964. CrossRef

153. ThompsonBF, FryLC, WellsCD, et al.The spectrum of GI strongyloidiasis: an endoscopic‐pathologic study. Gastrointest Endosc2004;59:906. CrossRef

154. LwinT, MeltonSD, GentaRM. Eosinophilic gastritis: histopathological characterization and quantification of the normal gastric eosinophil content. Mod Pathol2011;24:556. CrossRef

155. Pineton de ChambrunG, GonzalezF, CanvaJ‐Y, et al.Natural history of eosinophilic gastroenteritis. Clin Gastroenterol Hepatol2011;9:950. CrossRef

156. RothenbergME. Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol2004;113:11. CrossRef

157. TalleyNJ, ShorterRG, PhillipsSF, et al.Eosinophilic gastroenteritis: a clinicopathologic study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut1990;31:54. CrossRef

158. BarbieDA, MangiAA, LauwersGY. Eosinophilic gastroenteritis associated with systemic lupus erythematosus. J Clin Gastroenterol2004;38:883. CrossRef

159. GomezB, TabarAI, TunonT, et al.Eosinophilic gastroenteritis and Anisakis. Allergy1998;53:1148. CrossRef

160. RenaultM, GoodierA, SubramonyC, et al.Age‐related differences in granulomatous gastritis: a retrospective, clinicopathological analysis. J Clin Pathol2010;63:347. CrossRef

161. MaengL, LeeA, ChoiK, et al.Granulomatous gastritis: a clinicopathologic analysis of 18 biopsy cases. Am J Surg Pathol2004;28:941. CrossRef

162. ShapiroJL, GoldblumJR, PetrasRE. A clinicopathologic study of 42 patients with granulomatous gastritis: is there really an “idiopathic” granulomatous gastritis?Am J Surg Pathol1996;20:462. CrossRef

163. ShigematsuH, KuritaA, OmuraY, et al.Gastric cancer with sarcoid reactions in the regional lymph nodes, the stomach wall, and the splenic parenchyma: report of a case. Surg Today1999;29:549. CrossRef

164. AsakawaH, TsujiM, TokumineY, et al.Gastric T‐cell lymphoma presenting with epithelioid granulomas mimicking tuberculosis in regional lymph nodes. J Gastroenterol2001;36:190. CrossRef

165. LeachIH, MaclennanKA. Gastric lymphoma associatied with mucosal and nodal granulomas: a new differential diagnosis in granulomatous gastritis. Histopathology1990;17:87. CrossRef

166. EctorsNL, DixonMF, GeboesKJ, et al.Granulomatous gastritis: a morphological and diagnostic approach. Histopathology1993;23:55. CrossRef

167. OberhuberG, PuspokA, OesterreicherC, et al.Focally enhanced gastritis: a frequent type of gastritis in patients with Crohn's disease. Gastroenterology1997;112:698. CrossRef

168. ParenteF, CucinoC, BollaniS, et al.Focal gastric inflammatory infiltrates in inflammatory bowel diseases: prevalence, immunohistochemical characteristics, and diagnostic role. Am J Gastroenterol2000;95:705. CrossRef

169. SharifF, McDermottM, DillonM, et al.Focally enhanced gastritis in children with Crohn's disease and ulcerative colitis. Am J Gastroenterol2002;97:1415. CrossRef

170. XinW, GreensonJK. The clinical significance of focally enhanced gastritis. Am J Surg Pathol2004;28:1347. CrossRef

171. GrubelP, ChoiY, SchneiderD, et al.Severe isolated Crohn's‐like disease of the gastroduodenal tract. Dig Dis Sci2003;48:1360. CrossRef

172. YamamotoT, AllanRN, KeighleyMR. An audit of gastroduodenal Crohn disease: clinicopathologic features and management. Scand J Gastroenterol1999;34:1019. CrossRef

173. FiremanZ, SternbergA, YarchovskyY, et al.Multiple antral ulcers in gastric sarcoid. J Clin Gastroenterol1997;24:97. CrossRef

174. JevremovicD, TorbensonM, MurrayJA, et al.Atrophic autoimmune pangastritis: a distinctive form of antral and fundic gastritis associated with systemic autoimmune disease. Am J Surg Pathol2006;30:1412. CrossRef

175. RougemontA‐L, FournetJ‐C, MartinSR, et al.Chronic active gastritis in X‐linked lymphoproliferative disease. Am J Surg Pathol2008;32:323. CrossRef

176. CapellaC, FioccaR, CornaggiaM, et al.Autoimmune gastritis. In: GrahamD, GentaRM, DixonMF(eds). Gastritis. Philadephia: Lippincott Williams & Wilkins; 1999,79.

177. D'EliosMM, AppelmelkBJ, AmedeiA, et al.Gastric autoimmunity: the role of Helicobacter pylori and molecular mimicry. Trends Mol Med2004;10:316. CrossRef

178. TohB‐H, ChanJ, KyawT, et al.Cutting edge issues in autoimmune gastritis. Clin Rev Allergy Immunol2012;42:269. CrossRef

179. TorbensonM, AbrahamSC, BoitnottJ, et al.Autoimmune gastritis: distinct histological and immunohistochemical findings before complete loss of oxyntic glands. Mod Pathol2002;15:102. CrossRef

180. BrownIS, SmithJ, RostyC. Gastrointestinal pathology in celiac disease: a case series of 150 consecutive newly diagnosed patients. Am J Clin Pathol2012;138:42. CrossRef

181. WolberRA, OwenD, DelBuonoL, et al.Lymphocytic gastritis in patients with celiac sprue or spruelike intestinal disease. Gastroenterology1990;98:310.

182. WuTT, HamiltonSR. Lymphocytic gastritis: association with etiology and topology. Am J Surg Pathol1999;23:153. CrossRef

183. WolfsenHC, CarpenterHA, TalleyNJ. Menetrier's disease: a form of hypertrophic gastropathy or gastritis?Gastroenterology1993;104:1310.

184. PerardiS, TodrosL, MussoA, et al.Lymphocytic gastritis and protein‐losing gastropathy. Dig Liver Dis2000;32:422. CrossRef

185. BhattiTR, JatlaM, VermaR, et al.Lymphocytic gastritis in pediatric celiac disease. Pediatr Dev Pathol2011;14:280. CrossRef

186. Lagorce‐PagesC, FabianiB, BouvierR, et al.Collagenous gastritis: a report of six cases. Am J Surg Pathol2001;25:1174. CrossRef

187. StancuM, De PetrisG, PalumboTP, et al.Collagenous gastritis associated with lymphocytic gastritis and celiac disease. Arch Pathol Lab Med2001;125:1579.

188. LeungST, ChandanVS, MurrayJA, et al.Collagenous gastritis: histopathologic features and association with other gastrointestinal diseases. Am J Surg Pathol2009;33:788. CrossRef

189. QuinnCM, BjarnasonI, PriceAB. Gastritis in patients on non‐steroidal anti‐inflammatory drugs. Histopathology1993;23:341. CrossRef

190. MaguilnikI, NeumannWL, SonnenbergA, et al.Reactive gastropathy is associated with inflammatory conditions throughout the gastrointestinal tract. Aliment Pharmacol Ther2012;36:736. CrossRef

191. FiorucciS, AntonelliE, MorelliA. Mechanism of non‐steroidal anti‐inflammatory drug‐gastropathy. Dig Liver Dis2001;33(Suppl 2):S35. CrossRef

192. ZhangY, YangX, GuW, et al.Histological features of the gastric mucosa in children with primary bile reflux gastritis. World J Surg Oncol2012;10:27. CrossRef

193. KodaliVP, GordonSC. Gastrointestinal hemorrhage secondary to crack cocaine. Gastrointest Endosc1995;41:604. CrossRef

194. CurlingTB. On acute ulceration of the duodenum in cases of burn. Med Chir Trans, Second Series1842;25:260.

195. YangYX, LewisJD. Prevention and treatment of stress ulcers in critically ill patients. Semin Gastrointest Dis2003;14:11.

196. van der VoortPH, van der HulstRW, ZandstraDF, et al.Prevalence of Helicobacter pylori infection in stress‐induced gastric mucosal injury. Intensive Care Med2001;27:68. CrossRef

197. RajaK, KochlarR, SethyPK, et al.An endoscopic study of upper‐GI mucosal changes in patients with congestive heart failure. Gastrointest Endosc2004;60:887. CrossRef

198. KaptikS, JamalY, JacksonBK, et al.Ischemic gastropathy: an unusual cause of abdominal pain and gastric ulcers. Am J Med Sci2010;339:95. CrossRef

199. MerliM, NicoliniG, AngeloniS, et al.The natural history of portaly hypertensive gastropathy in patients with liver cirrhosis and mild portal hypertension. Am J Gastroenterol2004;99:1959. CrossRef

200. ThuluvathPJ, YooHY. Portal hypertensive gastropathy. Am J Gastroenterol2002;97:2973. CrossRef

201. StewartCA, SanyalAJ. Grading portal gastropathy: validation of a gastropathy scoring system. Am J Gastroenterol2003;98:1758. CrossRef

202. McCormackTT, SimsJ, Eyre‐BrookI, et al.Gastric lesions in portal hypertension: inflammatory gastritis or congestive gastropathy?Gut1985;26:1226. CrossRef

203. ChouraquiJP, RoyCC, BrochuP, et al.Menetrier's disease in children: report of a patient and review of sixteen other cases. Gastroenterology1981;80:1042.

204. MorinvilleV, BernardC, ForgetS. Foveolar hyperplasia secondary to cow's milk protein hypersensitivity presenting with clinical features of pyloric stenosis. J Pediatr Surg2001;39:E29. CrossRef

205. XiaoSY, HartJ. Marked gastric foveolar hyperplasia associated with active cytomegalovirus infection. Am J Gastroenterol2001;96:223. CrossRef

206. BurdickJS, ChungE, TannerG, et al.Treatment of Menetrier's disease with a monoclonal antibody against the epidermal growth factor receptor. N Engl J Med2000;343:1697. CrossRef

207. StojsicZM, StevanovicRM, StojanovicMM, et al.Histological features of gastric cardia in adults: an autopsy study. J Gastrointestin Liver Dis2011;20:13.

208. GoldblumJR, RichterJE, VaeziM, et al.Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa. Am J Gastroenterol2002;97:302. CrossRef

209. GentaRM, HiihormanRM, GrahamDY. The gastric cardia in Helicobacter pylori infection. Hum Pathol1994;25:915. CrossRef

210. VoutilainenM, FarkkilaM, JuholaM, et al.Complete and incomplete intestinal metaplasia at the oesophagogastric junction: prevalences and associations with endoscopic erosive oesophagitis and gastritis. Gut1999;45:644. CrossRef

211. WolfC, SeldenrijkCA, TimmerR, et al.Does carditis have two different etiologies?Dig Dis Sci2001;46:2424. CrossRef

212. GoldblumJR, VicariJJ, FalkGW, et al.Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection. Gastroenterology1998;114:633. CrossRef

213. LeodolterA, NoconM, ViethM, et al.Progression of specialized intestinal metaplasia at the cardia to macroscopically evident Barrett's esophagus: an entity of concern in the ProGERD study. Scand J Gastroenterol2012;47:1429. CrossRef

214. QuanteM, BhagatG, AbramsJA, et al.Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett‐like metaplasia. Cancer Cell2012;21:36. CrossRef

215. OrmsbyAH, VaeziMF, RichterJE, et al.Cytokeratin immunoreactivity patterns in the diagnosis of short‐segment Barrett's esophagus. Gastroenterology2000;119:683. CrossRef

216. el‐ZimaityHM, GrahamDY. Cytokeratin subsets for distinguishing Barrett's esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens. Am J Gastroenterol2001;96:1378. CrossRef

217. OhDS, DeMeesterSR, TanakaK, et al.The gene expression profile of cardia intestinal metaplasia is similar to that of Barrett's esophagus, not gastric intestinal metaplasia. Dis Esophagus2011;24:516. CrossRef